Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused ...

SHANGHAI, China I5, 2025 I YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Creative Biolabs With the enabling platforms and technologies at its disposal, Creative Biolabs is poised to address critical challenges in ...

Imagine if antibodies, proteins such as insulin, or even COVID-19 and flu vaccines could be consumed orally instead of via ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...

The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that ...

Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president ...

Researchers developed a cancer vaccine that uses tumor lysate to enhance immune recognition of solid tumors. The vaccine ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...